Randomized controlled trials are also needed to determine whether statins can actually reduce the risk for hepatocellular ...

Statin users had a significantly lower 10-year cumulative incidence of hepatocellular carcinoma and hepatic decompensation.

By that time the cholestasis was more pronounced, and there was slight focal or disseminated fatty degeneration. Neither hepatocellular necrosis nor evidence of reactive inflammation was found (Fig.

Hepatocellular carcinoma (HCC), the most common type of primary liver cancer, accounts for about 75–85% of all liver cancer cases. Immune checkpoint ...

This is called secondary liver cancer or liver metastases. Hepatocellular carcinoma is also called hepatoma or HCC. It's the most common type of primary liver cancer. Because of this, the information ...